Improving early diagnosis of pulmonary infections in patients with febrile neutropenia using low-dose chest computed tomography
- PMID: 28235014
- PMCID: PMC5325310
- DOI: 10.1371/journal.pone.0172256
Improving early diagnosis of pulmonary infections in patients with febrile neutropenia using low-dose chest computed tomography
Abstract
We performed a prospective study in patients with chemotherapy induced febrile neutropenia to investigate the diagnostic value of low-dose computed tomography compared to standard chest radiography. The aim was to compare both modalities for detection of pulmonary infections and to explore performance of low-dose computed tomography for early detection of invasive fungal disease. The low-dose computed tomography remained blinded during the study. A consensus diagnosis of the fever episode made by an expert panel was used as reference standard. We included 67 consecutive patients on the first day of febrile neutropenia. According to the consensus diagnosis 11 patients (16.4%) had pulmonary infections. Sensitivity, specificity, positive predictive value and negative predictive value were 36%, 93%, 50% and 88% for radiography, and 73%, 91%, 62% and 94% for low-dose computed tomography, respectively. An uncorrected McNemar showed no statistical difference (p = 0.197). Mean radiation dose for low-dose computed tomography was 0.24 mSv. Four out of 5 included patients diagnosed with invasive fungal disease had radiographic abnormalities suspect for invasive fungal disease on the low-dose computed tomography scan made on day 1 of fever, compared to none of the chest radiographs. We conclude that chest radiography has little value in the initial assessment of febrile neutropenia on day 1 for detection of pulmonary abnormalities. Low-dose computed tomography improves detection of pulmonary infiltrates and seems capable of detecting invasive fungal disease at a very early stage with a low radiation dose.
Conflict of interest statement
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - de Naurois J, Novitzky-Basso I, Gill MJ, Marti FM, Cullen MH, Roila F. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2010;21 Suppl 5:v252–6. - PubMed
 
- 
    - Yolin-Raley DS, Dagogo-Jack I, Niell HB, Soiffer RJ, Antin JH, Alyea EP 3rd, et al. The utility of routine chest radiography in the initial evaluation of adult patients with febrile neutropenia patients undergoing HSCT. Journal of the National Comprehensive Cancer Network: JNCCN. 2015;13(2):184–9. - PubMed
 
- 
    - Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011;52(4):e56–93. - PubMed
 
- 
    - Janssen A, van der Bruggen T, Haas PJ, de Jong PA, Minnema MC. Comparison of the occurrence of mold infection among patients receiving chemotherapy for acute leukemia versus patients undergoing stem cell transplantation. European journal of haematology. 2011;87(5):419–25. 10.1111/j.1600-0609.2011.01678.x - DOI - PubMed
 
MeSH terms
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        